Square Pharmaceuticals

Stock performance

History

Square Pharmaceuticals was founded as a small pharmaceutical manufacturer and grew into the largest drugmaker in Bangladesh, benefiting from the country's supportive 1982 national drug policy, which restricted foreign pharmaceutical imports to encourage domestic production capacity — a policy credit with helping Bangladesh become largely self-sufficient in essential medicines.

Business model

Square Pharmaceuticals manufactures generic and branded pharmaceutical products for the domestic Bangladeshi market and a growing export business to other developing markets, alongside a broader Square Group conglomerate spanning consumer goods and textiles.

Market position

Square Pharmaceuticals is the largest pharmaceutical company in Bangladesh by a significant margin, holding a leading share of the domestic drug market and increasingly exporting to other South Asian and African markets.

Country impact

Square Pharmaceuticals is one of the largest and most respected companies in Bangladesh, and its success is frequently cited as a model outcome of Bangladesh's 1980s drug-policy reforms, which are credited with building a globally competitive domestic generic-pharmaceutical industry.